AUSTRALIA'S #1 ONLINE CPD EDUCATION PLATFORM

How can we give ourselves the best chance of identifying possible lung cancer in our busy primary care practice?

This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.

This program aims to support identification, evaluation and treatment of patients at high risk of osteoporotic fracture.

This ALM explores how to initiate injectable therapy in a patient with type 2 diabetes who remains above their glycaemic target despite taking dual or triple oral therapy.
This module looks at the symptoms and management of common causes of vision loss and common eye conditions.
This module aims to improve GP confidence in managing early schizophrenia, including identifying and managing negative symptoms to reduce disability for their patients.

Busting the myths and redefining myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

ME/CFS is a complex, chronic, debilitating disease with systemic effects, which is estimated to affect up to 250,000 Australians. This module aims to educate GPs and others working in the primary care space about our evolving understanding of ME/CFS as an illness, and looks at some of the myths surrounding diagnosis and treatment.

Ensuring a patient-centred approach to care for people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Providing care for people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) requires a patient-centred approach with a focus on quality of life and incorporating the multidisciplinary team. This second module on ME/CFS provides detail on making a differential diagnosis, the non-core symptoms of ME/CFS, management in specific populations, and the development of a patient-centred treatment plan.

Individualising insulin options in type 2 diabetes: From initiation to intensification

Insulin therapy is a key part of glycaemic management in type 2 diabetes, and individualised treatment is central to providing optimal outcomes. This module outlines the tailored selection of insulin regimens for initiation and intensification, and the effective use of education and review to provide ongoing care.

Continuous glucose monitoring and flash glucose monitoring in type 2 diabetes

Continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) are new technologies that can assist in achieving effective glycaemic control in type 2 diabetes. This module explores the role of CGM and Flash GM in providing effective diabetes care, and provides guidance on interpreting glucose profiles and setting personalised targets.

IN Control clinical audit: INsulin INitiation and INtensification to avoid clinical INertia

Timely intensification of glucose-lowering medications to achieve target HbA1c is a key aspect of type 2 diabetes management. This program aims to support initiation or intensification of insulin therapy for patients who are currently not at their target HbA1c.

Pages